Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVTB
2801
DELISTED
PrivateBancorp Inc
PVTB
| $403K | ﹤0.01% |
+9,816
| New | +$412K |
|
2802
Daxor
DXR
$59.5M
| $402K | ﹤0.01% |
52,900
+200
| +0.4% | +$1.69K |
|
2803
Taylor Devices
TAYD
$172M
| $401K | ﹤0.01% |
24,300
+14,100
| +138% | +$216K |
|
|
I
2804
DELISTED
INTELSAT S. A.
I
| $395K | ﹤0.01% |
95,000
-160,926
| -63% | -$894K |
|
|
CGNT
2805
DELISTED
Cogentix Medical, Inc.
CGNT
| $395K | ﹤0.01% |
306,563
+24,200
| +9% | +$33.1K |
|
|
BVSN
2806
DELISTED
Broadvision Inc Com
BVSN
| $393K | ﹤0.01% |
65,500
+4,100
| +7% | +$24.6K |
|
2807
ReWalk Robotics
LFWD
$21.8M
| $392K | ﹤0.01% |
13
+4
| +44% | +$74.5K |
|
|
TISA
2808
DELISTED
TOP Image Systems Ltd
TISA
| $390K | ﹤0.01% |
128,700
+3,900
| +3% | +$13.2K |
|
|
EMMS
2809
DELISTED
Emmis Communications Corp
EMMS
| $390K | ﹤0.01% |
162,287
+11,449
| +8% | +$35.5K |
|
|
OLBK
2810
DELISTED
Old Line Bancshares, Inc.
OLBK
| $387K | ﹤0.01% |
+21,998
| New | +$387K |
|
2811
Gen Digital
GEN
$17.7B
| $386K | ﹤0.01% |
18,400
-1,831,538
| -99% | -$37.3M |
|
|
CARO
2812
DELISTED
Carolina Financial Corp.
CARO
| $384K | ﹤0.01% |
+21,323
| New | +$329K |
|
2813
Ingredion
INGR
$6.54B
| $383K | ﹤0.01% |
+4,000
| New | +$379K |
|
2814
Kingstone Companies
KINS
$284M
| $383K | ﹤0.01% |
42,514
+8,873
| +26% | +$82.1K |
|
|
SHI
2815
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $382K | ﹤0.01% |
+9,650
| New | +$387K |
|
2816
Hennessy Advisors
HNNA
$78.9M
| $380K | ﹤0.01% |
19,050
-2,760
| -13% | -$52.7K |
|
2817
Celestica
CLS
$43.8B
| $376K | ﹤0.01% |
34,000
-76,488
| -69% | -$881K |
|
2818
Protolabs
PRLB
$2.17B
| $376K | ﹤0.01% |
5,900
-71,600
| -92% | -$4.62M |
|
|
ACER
2819
DELISTED
Acer Therapeutics Inc
ACER
| $375K | ﹤0.01% |
12,988
+5,559
| +75% | +$184K |
|
2820
Amtech Systems
ASYS
$279M
| $373K | ﹤0.01% |
59,536
-35,300
| -37% | -$182K |
|
2821
Prologis
PLD
$134B
| $373K | ﹤0.01% |
+8,700
| New | +$367K |
|
|
ICD
2822
DELISTED
Independence Contract Drilling, Inc.
ICD
| $373K | ﹤0.01% |
3,695
+840
| +29% | +$106K |
|
|
GRO
2823
DELISTED
Agria Corp
GRO
| $373K | ﹤0.01% |
270,600
+14,000
| +5% | +$19.9K |
|
2824
Associated Banc-Corp
ASB
$6.07B
| $368K | ﹤0.01% |
19,600
+621
| +3% | +$12K |
|
2825
Eledon Pharmaceuticals
ELDN
$291M
| $368K | ﹤0.01% |
+260
| New | +$453K |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.